Shijiazhuang Yiling Pharmaceutical Co., Ltd. has systematically constructed the Collateral Disease Theory, built a new development pattern of “Integrating Theory, Clinical Treatment, R&D, Industrialization, and Education”. Yiling undertaken more than 60 research programs including the China National “973 Plan” programs, National“863 Plan” programs. Yiling has developed more than 10 patented new drugs. More than 800 patents have been obtained, and six national awards have been gained, including the First Prize of the National Science and Technology Progress Award.Yiling is a key national hi-tech enterprise with numerous honorary titles, such as Top 10 China TCM Company, Top 20 China Listed Pharmaceutical Company, Top 100 Most Valuable Chinese Brand, “National Advanced Grassroots Party Organization” by the CPC Central Committee, etc.